Correspondence re: C.V. Rao, et al., Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz. Cancer Res., 56: 3395–3398, 1996Letter

Roebuck, Bill D.; Rogers, Adrianne E.; Kensler, Thomas W.

Correspondence re: C.V. Rao, et al., Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz. Cancer Res., 56: 3395–3398, 1996: Letter

Bill D. Roebuck;

Bill D. Roebuck

Department of Pharmacology and Toxicology Dartmouth Medical School

Hanover, New Hampshire 03755

Search for other works by this author on:

This Site

PubMed

Google Scholar

Adrianne E. Rogers;

Adrianne E. Rogers

Department of Pathology Boston University School of Medicine

Boston, Massachusetts 02118

Search for other works by this author on:

This Site

PubMed

Google Scholar

Thomas W. Kensler

Department of Environmental Health Sciences The Johns Hopkins School of Hygiene and Public Health

Baltimore, Maryland 21205

Search for other works by this author on:

This Site

PubMed

Google Scholar

Received: October 09 1996

Accepted: May 13 1997

Online Issn: 1538-7445

Print Issn: 0008-5472

1997

American Association for Cancer Research, Inc.

Cancer Res (1997) 57 (13): 2806.

Correspondence re: C.V. Rao, et al., Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz. Cancer Res., 56: 3395–3398, 1996: Letter

Article PDF first page preview

Citing articles via

Email alerts

AACR Journals

Correspondence re: C.V. Rao, et al., Inhibition of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced Lymphoma Formation by Oltipraz. Cancer Res., 56: 3395–3398, 1996: Letter

Article PDF first page preview

Citing articles via

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only